HHS cuts funding to ‘under-tested’ mRNA technology for bird flu vaccines

The Ministry of Health and Humanitarian Services for president Donald Trump (HHS) finished the $ 750 million prizes that have been provided to the Moderna Pharmaceutical Factory to help facilitate its production of Flying Fluish Valomias based on Marna.

During the last week of President Joe Biden, his administration granted $ 590 million to Moderna to help accelerate its production from the vaccines based on us. The $ 590 million prize was a separate prize of $ 176 million awarded by Biden to Moderna earlier last year for a flexible vaccine technology.

Messenger RNA vaccines are the latest type of vaccine technology, which was used by companies such as Moderna and Pfizer to develop Covid-19 vaccines. Vaccine technology was in the center of many criticisms in the pandemic of the Coronvos virus due to its association with harmful side effects in some of the people they took, such as myocarditis.

The military husband and my mother from 5 battles with the return of the conflict on vaccines the permanent change of the family at the station

Trump administration officials previously alluded to the possibility of ending this funding, noting that there is no oversight during the Biden administration related to the production of vaccine.

“After a strict review, we concluded that the continued investment in the H5N1 MRNA vaccine in Moderna was not a scientific or moral justification,” said Andrew Nixon, HHS Director of Communications. “This is not only about effectiveness-it is related to safety, integrity and trust. The truth is that a flexible technique is still not a test, and we will not spend taxpayers taxes to repeat the mistakes of recent management, which hidden legitimate safety concerns from the public.”

The demonstrators who oppose Covid-19 vaccines and vaccine vaccines by the government’s mobilization in the city hall in New York City on August 25, 2021. (Angela Weiss/Agence Agency)

Trump FDA fixes the Covid-19 vaccine to focus on the oldest population, and individuals at risk

This announcement reflects a greater shift in the priorities of the federal vaccine, after the HHS Robert F. declared. Kennedy Junior earlier this week that Covid-19 vaccines will be removed from the recommended vaccine list from the federal government for children and pregnant women.

Meanwhile, a report issued by Republicans in the Senate, which was issued earlier this month, indicated that the Biden administration had blocked critical safety data and shrinked with the known risks associated with the Covid-19 vaccine. In particular, the Senate report focuses on HHS awareness of myocarditis, responding to it, and responding to cases of myocarditis-a type of heart inflammation-after the Covid-19 vaccination.

Amin HHS Robert F. Kennedy Junior earlier this week that the federal government will remove the Covid-19 vaccine on Marna from the list of recommended federal vaccines for children and pregnant women. (Getty Images/Fox News)

“Instead of providing public care providers and healthcare providers with immediate and transparent information regarding the risk of heart muscle inflammation after a COVID-19 vaccination, the Biden administration has waited until late June 2021 to announce changes in stickers in Moderna and Pfizer Covid-19 based on” increased risk “that suggested that he suggested mairine muscle inflammation.” From the fact that CDC and FDA officials were well aware of the risk of heart muscle inflammation after the Covid-19 vaccination, the Biden administration chose to block an official warning to the public for several months about safety concerns, which led to the health of American youth.

Click here to get the Fox News app

In response to the end of the Trump administration’s financing, Moderna issued a press statement acknowledged this step, but also promotes the “safety file”, which was observed among its work on the new bird flu vaccine.

“While finishing funding from HHS adds uncertainty, we are happy with the strong response to the immune response and safety that has been observed in this temporary analysis of the study of the 1/2 stage of our Petroleum Flu H5 and we will explore alternative paths forward to the program,” said Stefan Bansel, CEO of Moderna Modern. “This clinical data in the friendly influenza emphasizes the decisive role played by the technique of the Merseuled Rana as an anti -emerging health threats.”

Brock Centuman from Fox News Digital contributed to this report.